Top Articles

If your health has ever been negatively affected by a drug maker’s ne

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

gligence, you have the right to hold that company responsible and be

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ightfully compensated. This is especially in true in the case of dru

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

g manufacturer Eli Lilly and Co. downplaying important information ab

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ut harmful or deadly side effects from their drug Zyprexa®. Some of

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

the dangers of using Zyprexa® include developing diabetes, hyperglyce

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ia, pancreatits and even death from a diabetes-induced heart attack.

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

For over five years the warning signs for Zyprexa® have been surfaci

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

g but Eli Lily didn’t begin to acknowledge the problems until the FDA

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

intervened. The FDA finally ordered Eli Lily to change the label to

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

warn patients of dire complications after hundreds of users reported

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

complaints of diabetes, hyperglycemia, ketoacidosis, pancreatitis and

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

other symptoms.

So far there have been 288 cases of diabetes reporte

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

d in Zyprexa® patients, 23 which resulted in death. Although Eli Lil

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

y has acknowledged the dangerous side effects associated with the dru

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

g, consumer advocates point out that the warning references continue

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

o be hidden deep within the drug’s adverse reactions label.

A

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

get="_new" href="http://www.resource4zyprexainfo.com">Zyprexa Lawyer<

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

a> will help you get the compensation that you legally deserve. Don'

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

t hesitate. Contact a lawyer today for your free Zyprexa case review

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Does this sound familiar to you? Working and working and wanting to be your own boss but do not have the time or energy to live the lifestyle of your dreams.

Are you struggling to create a memorable positioning statement or USP for your marketing? Do you want to stand out from your competition, but the uniqueness of your business seems to elude you? Here’s a sneaky, vital secret that turns conventional marketing psychology on its head.

Revolving line of credit (RLoC) refers to the agreement between the borrower and the lender that specifies that the lender will give the borrower a facility of re-borrowing, once he has repaid the dues. There are two types of RLoCs: accounts receivables financing and inventory financing.

Tags

Links

Top Articles - Filing a Zyprexa(r) Lawsuit

Related Articles: